ArticleDrug safety2016

Linking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors.

Sirarat Sarntivijai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.